IRWD
NASDAQ · Biotechnology
Ironwood Pharmaceuticals Inc
$4.32
+0.06 (+1.41%)
Open$4.30
Previous Close$4.26
Day High$4.40
Day Low$4.21
52W High$5.78
52W Low$0.80
Volume—
Avg Volume2.62M
Market Cap711.95M
P/E Ratio6.97
EPS$0.58
SectorBiotechnology
Analyst Ratings
Buy
10 analysts
Price Target
+1,096.8% upside
Current
$4.32
$4.32
Target
$51.70
$51.70
$40.79
$51.70 avg
$62.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 305.84M | 341.03M | 73.58M |
| Net Income | 24.81M | 24.90M | 12.49M |
| Profit Margin | 8.1% | 7.7% | 17.0% |
| EBITDA | 103.66M | 109.81M | 23.02M |
| Free Cash Flow | — | — | 13.98M |
| Rev Growth | -10.3% | -10.3% | +11.9% |
| Debt/Equity | 0.61 | 0.61 | 0.47 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |